First assessment of a novel IGRT device for stereotactic body radiation therapy

M. Speiser, P. Medin, W. Mao, L. Papiez, F. Gum, T. Solberg

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Citations (Scopus)

Abstract

Introduction: A new device has been developed for image-guided Stereotactic Body Radiation Therapy (SBRT). The Vero SBRT System (known as "TM2000" in Japan), a joint product of MHI (Mitsubishi Heavy Industries Ltd., Tokyo, Japan) and BrainLAB (BrainLAB AG, Feldkir-chen, Germany) utilizes a rotating, rigid ring structure to integrate a beam delivery platform and image guidance systems. An inline 6 MV C-band LINAC with MLC is mounted on orthogonal gimbals that are in turn built into the ring structure. An electronic portal imaging device (EPID) and two kV imaging devices are also integrated in the ring. Opening commissioning measurements and stereotactic "hidden target" tests were performed to assess dosimetric and targeting characteristics as well as clinical capabilities of this SBRT dedicated device. Materials and Methods: Percent depth dose curves and beam profiles were measured in a water phantom and subsequently analyzed in accordance with industry standards. Additional characteristics including dose and dose rate linearity, relative output with varying field size, and output constancy with gantry angle were also evaluated. A commercial stereotactic phantom (LucyTM, Standard Imaging, Middleton, WI) was used to assess end-to-end localization accuracy of the image guidance system (through a "hidden-target" test) and for a comparison of absolute and relative dose against treatment planning calculations. Results: The essential characteristics of the Vero are com-mensurate with modern stereotactic requirements. Dosimetric characteristics are similar to other dedicated SRS/SBRT units, and end-to-end localization tests indicate sub-millimeter targeting accuracy. Conclusion: We have conducted preliminary commissioning and assessment of a novel device for image guided SBRT. Additionally, the integration of a gimbaled treatment beam, 2D and 3D imaging, tracking capabilities and real-time feed-back provide unique opportunity to develop and implement advanced SBRT delivery techniques.

Original languageEnglish (US)
Title of host publicationIFMBE Proceedings
Pages266-269
Number of pages4
Volume25
Edition1
DOIs
StatePublished - 2009
EventWorld Congress on Medical Physics and Biomedical Engineering: Radiation Oncology - Munich, Germany
Duration: Sep 7 2009Sep 12 2009

Other

OtherWorld Congress on Medical Physics and Biomedical Engineering: Radiation Oncology
CountryGermany
CityMunich
Period9/7/099/12/09

Fingerprint

Radiotherapy
Imaging techniques
Industry
Feedback
Planning
Water

Keywords

  • Image guidance
  • SBRT

ASJC Scopus subject areas

  • Biomedical Engineering
  • Bioengineering

Cite this

Speiser, M., Medin, P., Mao, W., Papiez, L., Gum, F., & Solberg, T. (2009). First assessment of a novel IGRT device for stereotactic body radiation therapy. In IFMBE Proceedings (1 ed., Vol. 25, pp. 266-269) https://doi.org/10.1007/978-3-642-03474-9-76

First assessment of a novel IGRT device for stereotactic body radiation therapy. / Speiser, M.; Medin, P.; Mao, W.; Papiez, L.; Gum, F.; Solberg, T.

IFMBE Proceedings. Vol. 25 1. ed. 2009. p. 266-269.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Speiser, M, Medin, P, Mao, W, Papiez, L, Gum, F & Solberg, T 2009, First assessment of a novel IGRT device for stereotactic body radiation therapy. in IFMBE Proceedings. 1 edn, vol. 25, pp. 266-269, World Congress on Medical Physics and Biomedical Engineering: Radiation Oncology, Munich, Germany, 9/7/09. https://doi.org/10.1007/978-3-642-03474-9-76
Speiser M, Medin P, Mao W, Papiez L, Gum F, Solberg T. First assessment of a novel IGRT device for stereotactic body radiation therapy. In IFMBE Proceedings. 1 ed. Vol. 25. 2009. p. 266-269 https://doi.org/10.1007/978-3-642-03474-9-76
Speiser, M. ; Medin, P. ; Mao, W. ; Papiez, L. ; Gum, F. ; Solberg, T. / First assessment of a novel IGRT device for stereotactic body radiation therapy. IFMBE Proceedings. Vol. 25 1. ed. 2009. pp. 266-269
@inproceedings{f4ee1b733c3545b2abdcf9d028c8f7d8,
title = "First assessment of a novel IGRT device for stereotactic body radiation therapy",
abstract = "Introduction: A new device has been developed for image-guided Stereotactic Body Radiation Therapy (SBRT). The Vero SBRT System (known as {"}TM2000{"} in Japan), a joint product of MHI (Mitsubishi Heavy Industries Ltd., Tokyo, Japan) and BrainLAB (BrainLAB AG, Feldkir-chen, Germany) utilizes a rotating, rigid ring structure to integrate a beam delivery platform and image guidance systems. An inline 6 MV C-band LINAC with MLC is mounted on orthogonal gimbals that are in turn built into the ring structure. An electronic portal imaging device (EPID) and two kV imaging devices are also integrated in the ring. Opening commissioning measurements and stereotactic {"}hidden target{"} tests were performed to assess dosimetric and targeting characteristics as well as clinical capabilities of this SBRT dedicated device. Materials and Methods: Percent depth dose curves and beam profiles were measured in a water phantom and subsequently analyzed in accordance with industry standards. Additional characteristics including dose and dose rate linearity, relative output with varying field size, and output constancy with gantry angle were also evaluated. A commercial stereotactic phantom (LucyTM, Standard Imaging, Middleton, WI) was used to assess end-to-end localization accuracy of the image guidance system (through a {"}hidden-target{"} test) and for a comparison of absolute and relative dose against treatment planning calculations. Results: The essential characteristics of the Vero are com-mensurate with modern stereotactic requirements. Dosimetric characteristics are similar to other dedicated SRS/SBRT units, and end-to-end localization tests indicate sub-millimeter targeting accuracy. Conclusion: We have conducted preliminary commissioning and assessment of a novel device for image guided SBRT. Additionally, the integration of a gimbaled treatment beam, 2D and 3D imaging, tracking capabilities and real-time feed-back provide unique opportunity to develop and implement advanced SBRT delivery techniques.",
keywords = "Image guidance, SBRT",
author = "M. Speiser and P. Medin and W. Mao and L. Papiez and F. Gum and T. Solberg",
year = "2009",
doi = "10.1007/978-3-642-03474-9-76",
language = "English (US)",
isbn = "9783642034725",
volume = "25",
pages = "266--269",
booktitle = "IFMBE Proceedings",
edition = "1",

}

TY - GEN

T1 - First assessment of a novel IGRT device for stereotactic body radiation therapy

AU - Speiser, M.

AU - Medin, P.

AU - Mao, W.

AU - Papiez, L.

AU - Gum, F.

AU - Solberg, T.

PY - 2009

Y1 - 2009

N2 - Introduction: A new device has been developed for image-guided Stereotactic Body Radiation Therapy (SBRT). The Vero SBRT System (known as "TM2000" in Japan), a joint product of MHI (Mitsubishi Heavy Industries Ltd., Tokyo, Japan) and BrainLAB (BrainLAB AG, Feldkir-chen, Germany) utilizes a rotating, rigid ring structure to integrate a beam delivery platform and image guidance systems. An inline 6 MV C-band LINAC with MLC is mounted on orthogonal gimbals that are in turn built into the ring structure. An electronic portal imaging device (EPID) and two kV imaging devices are also integrated in the ring. Opening commissioning measurements and stereotactic "hidden target" tests were performed to assess dosimetric and targeting characteristics as well as clinical capabilities of this SBRT dedicated device. Materials and Methods: Percent depth dose curves and beam profiles were measured in a water phantom and subsequently analyzed in accordance with industry standards. Additional characteristics including dose and dose rate linearity, relative output with varying field size, and output constancy with gantry angle were also evaluated. A commercial stereotactic phantom (LucyTM, Standard Imaging, Middleton, WI) was used to assess end-to-end localization accuracy of the image guidance system (through a "hidden-target" test) and for a comparison of absolute and relative dose against treatment planning calculations. Results: The essential characteristics of the Vero are com-mensurate with modern stereotactic requirements. Dosimetric characteristics are similar to other dedicated SRS/SBRT units, and end-to-end localization tests indicate sub-millimeter targeting accuracy. Conclusion: We have conducted preliminary commissioning and assessment of a novel device for image guided SBRT. Additionally, the integration of a gimbaled treatment beam, 2D and 3D imaging, tracking capabilities and real-time feed-back provide unique opportunity to develop and implement advanced SBRT delivery techniques.

AB - Introduction: A new device has been developed for image-guided Stereotactic Body Radiation Therapy (SBRT). The Vero SBRT System (known as "TM2000" in Japan), a joint product of MHI (Mitsubishi Heavy Industries Ltd., Tokyo, Japan) and BrainLAB (BrainLAB AG, Feldkir-chen, Germany) utilizes a rotating, rigid ring structure to integrate a beam delivery platform and image guidance systems. An inline 6 MV C-band LINAC with MLC is mounted on orthogonal gimbals that are in turn built into the ring structure. An electronic portal imaging device (EPID) and two kV imaging devices are also integrated in the ring. Opening commissioning measurements and stereotactic "hidden target" tests were performed to assess dosimetric and targeting characteristics as well as clinical capabilities of this SBRT dedicated device. Materials and Methods: Percent depth dose curves and beam profiles were measured in a water phantom and subsequently analyzed in accordance with industry standards. Additional characteristics including dose and dose rate linearity, relative output with varying field size, and output constancy with gantry angle were also evaluated. A commercial stereotactic phantom (LucyTM, Standard Imaging, Middleton, WI) was used to assess end-to-end localization accuracy of the image guidance system (through a "hidden-target" test) and for a comparison of absolute and relative dose against treatment planning calculations. Results: The essential characteristics of the Vero are com-mensurate with modern stereotactic requirements. Dosimetric characteristics are similar to other dedicated SRS/SBRT units, and end-to-end localization tests indicate sub-millimeter targeting accuracy. Conclusion: We have conducted preliminary commissioning and assessment of a novel device for image guided SBRT. Additionally, the integration of a gimbaled treatment beam, 2D and 3D imaging, tracking capabilities and real-time feed-back provide unique opportunity to develop and implement advanced SBRT delivery techniques.

KW - Image guidance

KW - SBRT

UR - http://www.scopus.com/inward/record.url?scp=77950393600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950393600&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-03474-9-76

DO - 10.1007/978-3-642-03474-9-76

M3 - Conference contribution

SN - 9783642034725

VL - 25

SP - 266

EP - 269

BT - IFMBE Proceedings

ER -